CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.620
+0.150 (4.32%)
At close: May 12, 2025, 4:00 PM
3.620
0.00 (0.00%)
After-hours: May 12, 2025, 5:11 PM EDT
CureVac Market Cap
CureVac has a market cap or net worth of $815.06 million as of May 12, 2025. Its market cap has increased by 57.53% in one year.
Market Cap
815.06M
Enterprise Value
356.65M
1-Year Change
57.53%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $815.06M, a decrease of -91.71%. That is a compound annual growth rate of -40.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 815.06M | 6.56% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 681.47B |
| Johnson & Johnson | 372.72B |
| UnitedHealth Group | 342.75B |
| AbbVie | 339.34B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.75B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |